Kevin Ariën

Medicine & Life Sciences

1. Anti-Infective Agents 100%
2. HIV-1 88%
3. HIV 76%
4. Reverse Transcriptase Inhibitors 69%
5. Chikungunya virus 68%
6. Viruses 59%
7. Disease Outbreaks 39%
8. Democratic Republic of the Congo 35%
9. Belgium 27%
10. Alphavirus 26%
11. Ebolavirus 23%
12. Infection 23%
13. Arboviruses 21%
14. Genotype 21%
15. Routine Diagnostic Tests 20%
16. Antiviral Agents 20%
17. Antibodies 19%
18. Culicidae 19%
19. Gels 18%
20. Coronavirus 17%
21. Severe Acute Respiratory Syndrome 16%
22. Triazines 16%
23. Immunoglobulin G 16%
24. Antigens 15%
25. T-Lymphocytes 15%
26. Mutation 15%
27. Dengue 15%
28. Foams and Jellies Vaginal Creams 14%
29. Anti-HIV Agents 14%
30. Immunoglobulin M 14%
31. Netherlands 13%
32. Primates 13%
33. Nanoparticles 12%
34. Pharmaceutical Preparations 12%
35. Proteins 12%
36. Neutralizing Antibodies 12%
37. Virus Diseases 11%
38. Genome 11%
39. Ebola Hemorrhagic Fever 11%
40. Coronavirus Spike Glycoproteins 10%
41. SARS Virus 10%
42. Crimean-Congo hemorrhagic fever virus 10%
43. Utopias 10%
44. Guinea-Bissau 10%
45. nef Gene Products 10%
46. Phenylalanine 9%
47. Viral Load 9%
48. Binding Sites 9%
49. Heterosexuality 9%
50. Sexually Transmitted Diseases 9%